CRL vs DCO · rev $2.00B vs rev $433.5M
Charles River Laboratories (CRL) versus Ducommun Incorporated (DCO) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Ducommun Incorporated (DCO) is a aerospace & defense company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported DCO revenue for 2026-07-04 was $433.5M. Net income was $30.3M. DCO currently screens at market cap $2.30B.
CRL currently screens at market cap $7.78B. DCO currently screens at market cap $2.30B.
Not investment advice. Open the CRL and DCO stock pages for the full models.
Not investment advice.